The epidemiology of HTLV-I in Europe

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Taylor, Graham P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Disease; Epidemiology; Europe; Human T lymphotropic virus type I; Infection

Indexed keywords

BLOOD DONOR; BREAST FEEDING; CONFERENCE PAPER; ENDEMIC DISEASE; EUROPE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INCIDENCE; INTRAVENOUS DRUG ABUSE; PREVALENCE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SPINAL CORD DISEASE; VERTICAL TRANSMISSION; VIRUS INFECTION;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 0029769605     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00003     Document Type: Conference Paper

References (58)

1. Catovsky D, Rose M, Goolden AWG, et al. Adult T-cell leukaemia/lymphoma in blacks from the West Indies. Lancet 1982;2:639-42.
2. Greaves MF, Verbi W, Tilley R, et al. Human T-cell leukaemia virus (HTLV) in the United Kingdom. Int J Cancer 1984;33:795-806.
3. Schaffar-Deshayes L, Chavance M, Monplaisir N, et al. Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with haematopoietic diseases in France and the French West Indies. Int J Cancer 1984;34:667-70.
4. Tedder RS, Shansson DC, Jeffries DJ, et al. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet 1984;2:125-7.
5. Born M, von der Helm K, Deinhardt F. HTLV and AIDS in West Germany. Lancet 1984;2:222.
6. Pandolfi F, Manzari V, De Rossi G, et al. T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Lancet 1985;2:633-6.
7. Manzari V, Gradilone A, Barillari G, et al. HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population. Int J Cancer 1985;36:557-9.
8. Del Mistro A, Calabro ML, Favero A, Chieco-Bianchi L. Epidemiology and etiopathology of human T-lymphotropic viruses: diagnostic and clinical implications from non-endemic areas. Tumori 1994;80:88-100.
9. HTLV European Research Network. The sero-epidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:1-10.
10. Anonymous. AIDS. Proposed WHO criteria for interpreting results from Western blot assay for HIV-1, HIV-2 and HTLV-I/II. Wkly Epidemiol Rec 1990;65:282-8.
11. Lemaire JM, Coste J, Courouce AM. HTLV-I en France. Presse Med 1988;17:1542.
12. Coste J, Lemaire JM, Barin F, Couroucé A-M, Retrovirus Study Group. HTLV-I/II antibodies in French blood donors. Lancet 1990;335:1167-8.
13. Pillonel J, Couroucé AM, Lemaire JM. HTLV-I/II infection amongst French blood donors. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:251.
14. Schatzl H, Schwarzfischer G, Rose D, et al. Prevalence of human T-cell lymphotropic virus infections in Germany. J Med Virol 1994;43:159-60.
15. Fleischer C, Ellerbrok H, Kücherer C, et al. Rare cases of HTLV-I infections in Germany originating from endemic areas. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10: 253.
16. Dalekos GN, Zervou E, Karabini F, Elisaf M, Bourantas K, Siamopoulos KC. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high risk groups in northwestern Greece. Transfusion 1995; 35:503-6.
17. Politis C, Economidou I, Fragatou S, et al. Prevalence of HTLV-I/II in blood donors and in multitransfused patients with thalasseamia and renal failure. Iatriki 1993;63:502-7.
18. de Stasio G, Reali G, Mannella E, et al. Studio policentrico di prevalenza dell'anti-HTLV I/II in donatori di sangue e in talassemici politrasfusi italiani. Giornale Ital AIDS 1995;6: 15-19.
19. Mannella E, Miceli M, Di Lorenzo A, Podagrosi D, Mercurio G, Gallo A. Prevalenza delle infezioni da HTLV-I e HTLV-II in donatori di sangue. Giornale Ital AIDS 1993;4: 219-23.
20. Icardi GC, Gabutti G, Wicks R, GIR (Gruppo Italiano Studio Retrovirus). HTLV-I and HTLV-II in Italy: a multicentre study. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:261.
21. Zaaijer HL, Cuypers HTM, Dudok de Wot C, Lelie PN. Results of 1 year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion 1994;34:877-80.
22. Andersson S, Tynell E, Lithander E, et al. Results of a one year screening of Swedish blood donors for HTLV. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:251.
23. Soriano V, Vellejo A, Gutiérrez M, Adelantado M, HTLV Spanish Study Group. Epidemiology of HTLV-I/II infections in Spain. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:251.
24. Brennan M, Runganga J, Barbara JAJ, et al. Prevalence of antibodies to human T-cell leukaemia/lymphoma virus in blood donors in north London. BMJ 1993;307:1235-9.
25. Salker R, Tosswill JHC, Barbara JAJ, et al. HTLV-I/II antibodies in UK blood donors. Lancet 1990;336:317.
26. Flanagan P, McAlpine L, Ramskill SJ, et al. Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors. Vox Sang 1995;68:220-4.
27. Ando Y, Nakano S, Saito K, et al. Transmission of ATL retrovirus (HTLV-I) from mother to child: comparison of bottle fed with breast fed babies. Jap J Cancer Res 1987;78: 322-4.
28. Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukaemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43:250-3.
29. Courtois F, Barin F, Larsen M, Brassard Y, Masselin A, Engelman P. HTLV-I/II infection in pregnant women in Paris. Lancet 1990;335:1103.
30. Pàdua E, Avillez F. Studies of HTLV-I/II seroprevalence among different population groups. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:262.
31. Parker SP, Taylor MB, Ades AE, Cubitt WD, Peckham C. Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. J Clin Pathol 1995;48:904-7.
32. Tosswill JHC, Ades AE, Peckham C, Mortimer P, Weber JN. Infection with human T-cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ 1990;301:95-6.
33. Janier M, Agbalika, Lassau F, et al. Prevalence des infections par les VIH 1, VIH 2 et HTLV 1. Experinece d'un centré des maladies sexuellement transmissible a Paris. Presse Med 1990;19:1747-50.
34. Chironna M, Calabrò ML, Quarto M, et al. HTLV-I and HTLV-II infections in Southeastern Italy. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:261.
35. Goudsmit J, de Wolf F, van de Wiel B, et al. Spread of human T-cell leukaemia virus (HTLV-I) in the Dutch homosexual community. J Med Virol 1987;23:115-21.
36. van Doornum GJJ, Hooykaas, Huisman JG, et al. Prevalence of human T-cell leukaemia virus antibody among heterosexuals living in Amsterdam, the Netherlands. J Med Virol 1990;32:183-8.
37. Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain. Eur J Clin Microbiol 1991;10:773-5.
38. Gradilone A, Zani M, Barillari G, et al. HTLV-I and HIV infection in drug addicts in Italy. Lancet 1986;2:753-4.
39. Soriano V, Tor J, Ribera A, et al. HIV-1, HIV-2 and HTLV-I infection in high-risk groups in Spain. AIDS 1989; 3:615-6.
40. Henrard DR, Soriano V, Robertson E, et al. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. J Clin Microbiol 1995;33:1735-8.
41. Christiansen CB, Wantzin P, Dickmeiss E. Prevalence of antibodies to HTLV-I/II in high risk patients and in blood donors in Denmark. Vox Sang 1995;68:63-4.
42. Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994;26:129-32.
43. Samdal HH, Skaug K, Bruun JN, Skar AG. Introduction of HTLV-II infection among Norwegian HIV positive injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:260.
44. Zehender G, De Maddalena C, Osio M, et al. High prevalence of human T-cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type-1 associated predominantly sensory polyneuropathy. J Infect Dis 1995;172:1595-8.
45. Murovska M, Taguchi H, Iwahara Y, Sawada T, Kukaine R, Miyoshi I. Antibodies to HTLV-I among blood donors in Latvia, USSR. Int J Cancer 1991;47:158-9.
46. Paun L, Ispas D, Del Mistro A, Chieco-Bianchi L. HTLV-I in Romania. Eur J Haematol 1994;52:117-8.
47. Gurtsevitch V. Proceedings International Conference on AIDS, St. Petersberg, 1992, p 44.
48. Mayer V. First cases of human T-lymphotropic virus type 1 infection observed in Slovakia. Acta Virol Praha 1991;35: 203.
49. Cobic P, Keserovic N, Radovanavic Z. HIV-1 and HTLV-1 infections among intravenous drug abusers in Belgrade, Yugoslavia. J Acquir Immune Defic Syndr 1990;3:1197-9.
50. Gessain A, Gout O, Saal F, et al. Epidemiology and immunovirology of human T-cell leukaemia/lymphoma virus type-I associated adult t-cell leukaemia and chronic myelopathies as seen in France. Cancer Res 1990;50(Suppl):5692s-6s.
51. Simms I, Tosswill JHC, Noone A, Morgan D. Surveillance of HTLV infection in England and Wales 1986-92. CDR Rev 1994;4:R65-9.
52. Del Mistro A, Rinaldi R, Raimondi R, et al. Adult T-cell leukemia (ATL): clinical, pathological and virological findings in two cases with unusual features. Leukemia Lymphoma 1992;6:261-6.
53. Soriano V, Gutiérrez M, Vallejo A, et al. HTLV-I associated illnesses in Spain. Vox Sang 1995;69:261-2
54. Senjuta N, Pavlish O, Gurtsevitch V. Case of adult T-cell leukaemia in HTLV-I infected family in Georgia, USSR. Lancet 1991;338:1394.
55. Kiss J, Telek B, Toth FD, Rejto L, Suranyi P, Rak K. HTLV-related markers in a Hungarian patient with adult T-cell leukaemia. Leuk Res 1992;16:1125-31.
56. de Saussure Ph, Chofflon M, Pugin P, Bierens de Hahn D, Perrin L. HTLV-I/II en Suisse: à propos de quatre observations. Schwiez Med Wschr 1991;121:1761-6.
57. Kitze E, Turner RW, Burchhardt M, Poser S, Hunsmann G, Weber T. Differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis in Iranian patients. Clin Invest 1992;70:1013-8.
58. Taylor GP, Warne M, Sandy C, Steiger M, Weber JN. HTLV-I associated uveitis. Eye 1996;10 (in press).